tiprankstipranks
Trending News
More News >
Corcept Therapeutics Inc. (CORT)
NASDAQ:CORT
US Market

Corcept Therapeutics (CORT) Ratios

Compare
994 Followers

Corcept Therapeutics Ratios

CORT's free cash flow for Q1 2025 was $0.98. For the 2025 fiscal year, CORT's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
6.11 4.39 6.11 55.21 49.67
Quick Ratio
5.90 4.31 5.90 52.61 47.67
Cash Ratio
5.35 1.30 5.35 48.61 45.19
Solvency Ratio
1.28 0.93 1.28 2.41 2.24
Operating Cash Flow Ratio
1.47 1.22 1.47 24.30 14.40
Short-Term Operating Cash Flow Coverage
105.27 0.00 105.27 319.19 0.00
Net Current Asset Value
$ 417.12M$ 343.82M$ 417.12M$ 333.44M$ 475.85M
Leverage Ratios
Debt-to-Assets Ratio
<0.01 <0.01 <0.01 <0.01 <0.01
Debt-to-Equity Ratio
<0.01 <0.01 <0.01 <0.01 <0.01
Debt-to-Capital Ratio
<0.01 <0.01 <0.01 <0.01 <0.01
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.16 1.23 1.16 1.13 1.09
Debt Service Coverage Ratio
20.82 0.00 20.82 212.90 0.00
Interest Coverage Ratio
31.67 0.00 31.67 0.00 0.00
Debt to Market Cap
<0.01 0.00 <0.01 <0.01 0.00
Interest Debt Per Share
0.04 <0.01 0.04 <0.01 0.02
Net Debt to EBITDA
-3.87 -1.25 -3.87 -2.69 -3.64
Profitability Margins
Gross Profit Margin
98.66%98.66%98.66%98.56%98.42%
EBIT Margin
28.91%22.24%28.91%34.16%36.23%
EBITDA Margin
28.03%22.46%28.03%34.01%36.86%
Operating Profit Margin
28.03%22.24%28.03%34.01%36.23%
Pretax Profit Margin
28.91%25.82%28.91%34.16%37.19%
Net Profit Margin
25.24%22.00%25.24%30.74%29.96%
Continuous Operations Profit Margin
25.24%22.00%25.24%30.74%29.96%
Net Income Per EBT
87.29%85.21%87.29%90.01%80.55%
EBT Per EBIT
103.16%116.10%103.16%100.42%102.65%
Return on Assets (ROA)
17.38%17.08%17.38%26.55%18.54%
Return on Equity (ROE)
20.21%20.95%20.21%29.94%20.26%
Return on Capital Employed (ROCE)
22.44%20.75%22.44%29.86%22.85%
Return on Invested Capital (ROIC)
19.50%17.68%19.50%26.81%18.34%
Return on Tangible Assets
17.38%17.08%17.38%20.99%17.44%
Earnings Yield
4.68%3.16%4.68%4.91%3.51%
Efficiency Ratios
Receivables Turnover
12.94 11.73 12.94 13.25 13.51
Payables Turnover
0.45 0.37 0.45 0.76 0.53
Inventory Turnover
0.32 0.84 0.32 0.29 0.26
Fixed Asset Turnover
351.58 1.53K 351.58 712.02 141.04
Asset Turnover
0.69 0.78 0.69 0.86 0.62
Working Capital Turnover Ratio
1.02 1.25 1.02 0.82 0.86
Cash Conversion Cycle
370.84 -513.26 370.84 790.73 720.34
Days of Sales Outstanding
28.21 31.12 28.21 27.55 27.02
Days of Inventory Outstanding
1.15K 435.34 1.15K 1.24K 1.38K
Days of Payables Outstanding
811.74 979.72 811.74 477.45 690.11
Operating Cycle
1.18K 466.46 1.18K 1.27K 1.41K
Cash Flow Ratios
Operating Cash Flow Per Share
1.13 1.23 1.13 1.45 1.32
Free Cash Flow Per Share
1.12 1.23 1.12 1.45 1.31
CapEx Per Share
<0.01 <0.01 <0.01 <0.01 0.01
Free Cash Flow to Operating Cash Flow
1.00 1.00 1.00 1.00 0.99
Dividend Paid and CapEx Coverage Ratio
291.34 913.95 291.34 357.98 122.75
Capital Expenditure Coverage Ratio
291.34 913.95 291.34 357.98 122.75
Operating Cash Flow Coverage Ratio
105.27 841.32 105.27 319.19 59.57
Operating Cash Flow to Sales Ratio
0.30 0.26 0.30 0.46 0.43
Free Cash Flow Yield
5.53%3.77%5.53%7.31%4.99%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
21.39 31.69 21.39 20.35 28.48
Price-to-Sales (P/S) Ratio
5.40 6.97 5.40 6.26 8.53
Price-to-Book (P/B) Ratio
4.32 6.64 4.32 6.09 5.77
Price-to-Free Cash Flow (P/FCF) Ratio
18.09 26.51 18.09 13.68 20.03
Price-to-Operating Cash Flow Ratio
18.03 26.48 18.03 13.64 19.87
Price-to-Earnings Growth (PEG) Ratio
-10.37 4.30 -10.37 3.74 2.34
Price-to-Fair Value
4.32 6.64 4.32 6.09 5.77
Enterprise Value Multiple
15.39 29.80 15.39 15.70 19.51
Enterprise Value
1.73B 3.23B 1.73B 1.95B 2.54B
EV to EBITDA
15.39 29.80 15.39 15.70 19.51
EV to Sales
4.31 6.69 4.31 5.34 7.19
EV to Free Cash Flow
14.46 25.44 14.46 11.67 16.88
EV to Operating Cash Flow
14.41 25.41 14.41 11.64 16.75
Tangible Book Value Per Share
4.70 4.89 4.70 3.25 4.53
Shareholders’ Equity Per Share
4.70 4.89 4.70 3.25 4.53
Tax and Other Ratios
Effective Tax Rate
0.13 0.15 0.13 0.10 0.19
Revenue Per Share
3.76 4.66 3.76 3.16 3.07
Net Income Per Share
0.95 1.02 0.95 0.97 0.92
Tax Burden
0.87 0.85 0.87 0.90 0.81
Interest Burden
1.00 1.16 1.00 1.00 1.03
Research & Development to Revenue
0.33 0.38 0.33 0.31 0.32
SG&A to Revenue
0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.11 0.10 0.11 0.12 0.09
Income Quality
1.19 1.20 1.19 1.49 1.43
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis